Wall Street analysts expect Proto Labs, Inc. (NYSE:PRLB) to announce sales of $85.53 million for the current quarter, Zacks reports. Three analysts have provided estimates for Proto Labs’ earnings. The highest sales estimate is $85.99 million and the lowest is $85.30 million. Proto Labs posted sales of $78.17 million during the same quarter last year, which suggests a positive year-over-year growth rate of 9.4%. The firm is expected to report its next earnings report on Thursday, October 26th.

On average, analysts expect that Proto Labs will report full-year sales of $85.53 million for the current fiscal year, with estimates ranging from $333.89 million to $336.70 million. For the next fiscal year, analysts anticipate that the business will post sales of $369.60 million per share, with estimates ranging from $366.39 million to $374.31 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Proto Labs.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings results on Thursday, July 27th. The industrial products company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.43 by $0.06. Proto Labs had a return on equity of 11.75% and a net margin of 14.59%. The firm had revenue of $82.04 million during the quarter, compared to analysts’ expectations of $80.49 million. During the same quarter last year, the firm earned $0.45 earnings per share. The business’s revenue for the quarter was up 9.4% on a year-over-year basis.

A number of equities research analysts have issued reports on the stock. Piper Jaffray Companies reissued a “hold” rating and set a $67.00 target price on shares of Proto Labs in a research note on Friday, July 28th. Zacks Investment Research lowered shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 28th. Dougherty & Co raised shares of Proto Labs from a “sell” rating to a “neutral” rating in a research note on Tuesday, June 27th. Finally, TheStreet raised shares of Proto Labs from a “c+” rating to a “b-” rating in a research note on Friday, May 5th. Four analysts have rated the stock with a hold rating, The company presently has a consensus rating of “Hold” and an average price target of $60.75.

TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/brokerages-anticipate-proto-labs-inc-prlb-will-post-quarterly-sales-of-85-53-million/1532576.html.

Proto Labs (NYSE:PRLB) traded up 1.57% during midday trading on Friday, hitting $71.20. The company had a trading volume of 179,827 shares. The stock’s 50-day moving average price is $71.52 and its 200-day moving average price is $61.50. The stock has a market cap of $1.89 billion, a PE ratio of 41.40 and a beta of 0.93. Proto Labs has a 52-week low of $43.10 and a 52-week high of $75.55.

In related news, VP Robert Bodor sold 3,259 shares of Proto Labs stock in a transaction on Wednesday, July 19th. The shares were sold at an average price of $72.02, for a total value of $234,713.18. Following the transaction, the vice president now owns 19,837 shares in the company, valued at approximately $1,428,660.74. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 7.78% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Gs Investments Inc. purchased a new position in shares of Proto Labs during the second quarter valued at approximately $6,158,000. Lord Abbett & CO. LLC purchased a new position in shares of Proto Labs during the second quarter valued at approximately $21,351,000. Grandeur Peak Global Advisors LLC increased its position in shares of Proto Labs by 2.6% in the second quarter. Grandeur Peak Global Advisors LLC now owns 43,375 shares of the industrial products company’s stock valued at $2,917,000 after buying an additional 1,100 shares during the period. Piedmont Investment Advisors LLC purchased a new position in shares of Proto Labs during the second quarter valued at approximately $354,000. Finally, Summit Partners Public Asset Management LLC purchased a new position in shares of Proto Labs during the second quarter valued at approximately $2,018,000.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.